ANAVEX LIFE SCIENCES CORP. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
AVXL on Nasdaq
Location
New York, NY
Fiscal year end
30 September
Latest financial report
09 Feb 2026

Latest SEC snapshot (2025-12-31) highlights Return On Equity -33.6%, Return On Assets -31.1%, and NetIncomeLoss YoY 14.1%.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

22.9/100

Weak Confidence low

Return On Equity

-34%

Metric score 0.0/100

Return On Assets

-31%

Metric score 0.0/100

Financial Health

Strengths

NetIncomeLoss YoY

Watchpoints

Return On Equity and Return On Assets

Key metrics snapshot

Return On Equity

-34%

YoY: -11%

Industry median: -48% (n=217)

View history

Return On Assets

-31%

YoY: -9%

Industry median: -46% (n=216)

View history

NetIncomeLoss YoY

14%

YoY:

Industry median: -9.9% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -34% -11%
Return On Assets -31% -9%

Financial Health

Metric Latest value YoY change
Debt-to-equity 0.11x +6.8%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY 14%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 89,348,107 +5.3%
Common Stock, Shares, Outstanding 92,671,758 +9%
Common Stock, Value, Issued $93,000 +9.4%
Weighted Average Number of Shares Outstanding, Basic 89,029,458 +5%
Weighted Average Number of Shares Outstanding, Diluted 89,029,458 +5%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $31,802,000 -27%
General and Administrative Expense $12,796,000 +11%
Operating Income (Loss) $44,598,000 +19%
Nonoperating Income (Expense) $4,669,000 -46%
Income Tax Expense (Benefit) $18,000
Earnings Per Share, Basic -0.46 +16%
Earnings Per Share, Diluted -0.46 +16%
Cash and Cash Equivalents, at Carrying Value $131,749,000 +9.1%
Assets $132,989,000 +7.2%
Accounts Payable, Current $2,639,000 -42%
Accrued Liabilities, Current $2,927,000 -62%
Liabilities $6,371,000 -51%
Retained Earnings (Accumulated Deficit) $388,129,000 -11%
Stockholders' Equity Attributable to Parent $126,618,000 +14%
Liabilities and Equity $132,989,000 +7.2%
Share-based Payment Arrangement, Noncash Expense $10,601,000 +15%
Net Cash Provided by (Used in) Operating Activities $7,151,000 +41%
Net Cash Provided by (Used in) Financing Activities $36,323,000 +5030%
Common Stock, Shares Authorized 200,000,000 0%
Common Stock, Shares, Issued 92,671,758 +9%
Common Stock, Par or Stated Value Per Share 0.001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $131,749,000 +9.1%
Preferred Stock, Shares Authorized 10,000,000 0%
Share-based Payment Arrangement, Expense $10,500,000 +14%
Preferred Stock, Par or Stated Value Per Share 0.001 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%